How many people with diabetic peripheral neuropathy have cardiac autonomic neuropathy?

Not yet recruiting

Conditions: Endocrine, nutritional and metabolic diseases,

Registration Number: CTRI/2019/10/021742

Lead Sponsor: KASTURBA MEDICAL COLLEGE

Brief Summary: This is a cross sectional study where patients with diabetic peripheral neuropathy admitted in medicine ward (with symptoms and/signs of neuropathy) will be recruited and screened for cardiac autonomic neuropathy by the department of physiology.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 233

Inclusion Criteria

Diabetic peripheral neuropathy(with h/o diabetes and symptoms and/or signs of diabetic peripheral neuropathy), NCV.

Exclusion Criteria

Patients taking beta blockers, clonidine, prazosin, steroids, ohenytoin, cisplatin, vincristine, amiodarone, fluoroquinolones, metronidazole, isoniazid, nitrofurantoin chronic kidney disease h/o significant alcohol intake vitamin b12 deficiency HIV Severe systemic disease(cardiac, pulmonary, malignancy) Unstable patient(A/E COPD, Bronchial asthma, severe HTN, ECG s/o myocardial ischemia or infarct).

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of autonomic neuropathy in patients who have diabetic peripheral neuropathy	3 years

Secondary Outcome Measures

Name	Time	Method
Autonomic dysfunction stages correlation with various types of diabetic peripheral neuropathy and their severity	Autonomic dysfunction correlation with hypoglycemia and neuroglycopenia

Trial Locations

Locations (1): KASTURBA HOSPITAL
🇮🇳
Udupi, KARNATAKA, India
KASTURBA HOSPITAL
🇮🇳Udupi, KARNATAKA, India
DR POONAM KAMATH
Principal investigator
8317402192
poonamkamath1995@gmail.com